Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
- Analysis Platform
- Language
- Publication Date
101 - 117 of 117 results
Applied Filters
This quick reference guide describes the data analysis features within the xCELLigence RTCA eSight software (310100310).
Customer story featuring UCLA Med school professor Dr.Robert Prins using xCELLigence technology.
Increased flexibility, complete data and more insight into cell health and behavior with the xCELLigence RTCA DP instrument.
必威体育登录手机This quick reference guide describes common procedures for maintenance of the Agilent xCELLigence RTCA HT Station (part number 5919878001).It is suggested that maintenance be performed as described.
必威体育登录手机This white paper is a resource for users of Agilent xCELLigence RTCA S16, DP, TP, SP, MP, and HT systems whose organizations must comply with Title 21 CFR Part 11.
Immune cell mediated killing potency assay flyer documenting the advantages of using xCELLigence real-time cell analyzers for functional potency assays, including 21 CRF Part 11 compliance.
必威体育登录手机Agilent xCELLigence RTCA HT instrument with Agilent BioTek BioSpa 8 automated incubator integration expands screening throughput of your RTCA HT instrument to eight 384-well plates.
必威体育登录手机The Agilent xCELLigence Real-Time Cell Analyzer RTCA S16 can now be yours at a discounted rate of $9,950* when you order online.
Expanded xCELLigence RTCA eSight software capabilities in Cell Health and Viability, Immuno-Oncology space spanning Wound Healing, Cell by Cell Analysis, Immunotherapy, Dilution Cloning, and 3D Tumor Invasion.
必威体育登录手机The Agilent xCELLigence Real-Time Cell Analyzer (RTCA) S16 is now available for purchase through the Agilent online store.
必威体育登录手机The Agilent xCELLigence Real-Time Cell Analyzer RTCA S16 can now be yours at a discounted rate of $9,950* when you order online.
必威体育登录手机The Agilent xCELLigence Real-Time Cell Analyzer RTCA S16 can now be yours at a discounted rate of $9,950* when you order online.
Several key opinion leaders tell GEN how they are using the xCELLigence RTCA platform to study immune cell-mediated killing.
Although cell therapies have shown great promise in clinical studies, challenges with the large scale manufacturing of these therapies still need to be addressed.
Measure and quantify apoptosis, proliferation, cytotoxicity, cell death, and nuclear labeling using various live cell imaging reagents.
Dr.Daniel Hui from Tmunity Therapeutics addresses challenges with cell therapy development with an innovative CAR-T toolbox, using xCELLigence RTCA for measuring potency of immune cell therapies.
The rapid and high-throughput xCELLigence Real-Time Cell Analysis workflow is ideal for infectious viral assays.